Nighan Warren JR
SVP Quality and Regulatory
SaleAlert
- Shares
- 23,370
- Price
- $14.72
- Value
- $344,006
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•27 filings
ANGO
ANGIODYNAMICS INC
Net sales of $344K over the last 3 months
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$344,006
0 buyers · 1 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$344,006
1 distinct insiders
Highlighted alerts
4
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get ANGO insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
ANGO overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
54
Raw transactions
Everything returned by the filing
4
Voluntary view
P/S trades after deterministic checks
50
Administrative noise
Stored, never alerted
0
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- F
- Shares
- 4,506
- Price
- $13.82
- Footnotes
- 3
This acquisition of 8,047 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023. The exempt disposition of 4,506 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023. On July 19, 2023, the reporting person received a target grant of 28,336 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,047 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Weiss Lawrence T
SVP, Chief Legal Officer
PurchaseAlert
- Shares
- 10,000
- Price
- $11.81
- Value
- $118,100
Trowbridge Stephen A
EVP and CFO
PurchaseAlert
- Shares
- 890
- Price
- $11.16
- Value
- $9,932
Clemmer James C
President and CEO
PurchaseAlert
- Shares
- 10,000
- Price
- $11.15
- Value
- $111,500
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Nighan Warren JR SVP Quality and Regulatory | Sale | 23,370 | $14.72 | $344,006 | |
| Oct 21, 2025 | Weiss Lawrence T SVP, Chief Legal Officer | Purchase | 10,000 | $11.81 | $118,100 | |
| Oct 13, 2025 | Trowbridge Stephen A EVP and CFO | Purchase | 890 | $11.16 | $9,932 | |
| Oct 09, 2025 | Clemmer James C President and CEO | Purchase | 10,000 | $11.15 | $111,500 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.